200 related articles for article (PubMed ID: 9986765)
21. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
22. Proton MRS in Kennedy disease: absolute metabolite and macromolecular concentrations.
Mader I; Karitzky J; Klose U; Seeger U; Sperfeld A; Naegele T; Schick F; Ludolph A; Grodd W
J Magn Reson Imaging; 2002 Aug; 16(2):160-7. PubMed ID: 12203763
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.
Reynolds NC; Prost RW; Mark LP
Brain Res; 2005 Jan; 1031(1):82-9. PubMed ID: 15621015
[TBL] [Abstract][Full Text] [Related]
24. 13C magnetic resonance spectroscopy studies of alterations in glutamate neurotransmission.
Shen J
Biol Psychiatry; 2006 May; 59(10):883-7. PubMed ID: 16199016
[TBL] [Abstract][Full Text] [Related]
25. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
[TBL] [Abstract][Full Text] [Related]
26. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
27. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion.
Moreno A; Ross BD; Blüml S
J Neurochem; 2001 Apr; 77(1):347-50. PubMed ID: 11279290
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy.
Lin K; Carrete H; Lin J; Peruchi MM; de Araújo Filho GM; Guaranha MS; Guilhoto LM; Sakamoto AC; Yacubian EM
Epilepsia; 2009 May; 50(5):1191-200. PubMed ID: 19220412
[TBL] [Abstract][Full Text] [Related]
29. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
Kickler N; Krack P; Fraix V; Lebas JF; Lamalle L; Durif F; Krainik A; Rémy C; Segebarth C; Pollak P
NMR Biomed; 2007 Dec; 20(8):757-62. PubMed ID: 17334978
[TBL] [Abstract][Full Text] [Related]
30. MR spectroscopic studies of the brain in psychiatric disorders.
Maddock RJ; Buonocore MH
Curr Top Behav Neurosci; 2012; 11():199-251. PubMed ID: 22294088
[TBL] [Abstract][Full Text] [Related]
31. Localized sensitivity enhanced in vivo 13C MRS to detect glucose metabolism in the mouse brain.
Nabuurs CI; Klomp DW; Veltien A; Kan HE; Heerschap A
Magn Reson Med; 2008 Mar; 59(3):626-30. PubMed ID: 18224699
[TBL] [Abstract][Full Text] [Related]
32. Difference spectroscopy using PRESS asymmetry: application to glutamate, glutamine, and myo-inositol.
Snyder J; Thompson RB; Wilman AH
NMR Biomed; 2010 Jan; 23(1):41-7. PubMed ID: 19688783
[TBL] [Abstract][Full Text] [Related]
33. Validation of in vivo MRS measures of metabolite concentrations in the human brain.
Dhamala E; Abdelkefi I; Nguyen M; Hennessy TJ; Nadeau H; Near J
NMR Biomed; 2019 Mar; 32(3):e4058. PubMed ID: 30663818
[TBL] [Abstract][Full Text] [Related]
34. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
Lin AP; Shic F; Enriquez C; Ross BD
MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884
[TBL] [Abstract][Full Text] [Related]
35. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
Harris K; Lin A; Bhattacharya P; Tran T; Wong W; Ross B
Adv Exp Med Biol; 2006; 576():263-73; discussion 361-3. PubMed ID: 16802718
[No Abstract] [Full Text] [Related]
36. Investigating brain metabolism at high fields using localized 13C NMR spectroscopy without 1H decoupling.
Deelchand DK; Uğurbil K; Henry PG
Magn Reson Med; 2006 Feb; 55(2):279-86. PubMed ID: 16345037
[TBL] [Abstract][Full Text] [Related]
37. In vivo investigation of glutamate-glutamine metabolism in hyperammonemic monkey brain using 13C-magnetic resonance spectroscopy.
Tsukada Y; Kanamatsu T; Watanabe H; Okamoto K
Dev Neurosci; 1998; 20(4-5):427-33. PubMed ID: 9778581
[TBL] [Abstract][Full Text] [Related]
38. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T.
Wellard RM; Briellmann RS; Jennings C; Jackson GD
AJNR Am J Neuroradiol; 2005 Mar; 26(3):585-90. PubMed ID: 15760870
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels.
Bustillo J; Barrow R; Paz R; Tang J; Seraji-Bozorgzad N; Moore GJ; Bolognani F; Lauriello J; Perrone-Bizzozero N; Galloway MP
Neuropsychopharmacology; 2006 Apr; 31(4):751-6. PubMed ID: 16132064
[TBL] [Abstract][Full Text] [Related]
40. Proton spectroscopy of brain glutamine in acute liver failure.
McConnell JR; Antonson DL; Ong CS; Chu WK; Fox IJ; Heffron TG; Langnas AN; Shaw BW
Hepatology; 1995 Jul; 22(1):69-74. PubMed ID: 7601435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
